Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Nurses' AI attitudes and thinking skills under the microscope

NCT ID NCT07134374

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study surveyed 294 nurses at a Turkish hospital to see if their attitudes toward artificial intelligence are linked to their critical thinking skills. Researchers used two validated questionnaires to measure both traits. The goal was to understand how nurses might adapt to AI tools in healthcare, but the study only looked at the relationship between these two factors, not at any treatment or intervention.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

294 people

The number who actually took part.

Started

Aug 2025

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Registered nurses

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Nurses who are actively working in a university hospital, * Have at least 6 months of professional experience, and * Are willing to participate in the research. Exclusion Criteria: * Refusal to Participate: Nurses who declined to participate in the study or who did not wish to sign the informed consent form. * On Leave: Nurses who are on leave, annual leave, maternity leave, or parental leave during the conduct of the study. * Communication Barriers: Nurses with language barriers that significantly impair their ability to read and understand the questionnaire or who are known to have severe cognitive impairments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NURSES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Turkish Ministry of Health, Adana City Training and Research Hospital

    Sinop, Sinop, 57000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.